Position in RVMD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$393,662
New position
Shares Held
2,102
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#457
of 685 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRIGLAV INVESTMENTS, D.O.O. holds $5,956,452 across 7 Biotechnology names. RVMD ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,000 | $1,870,620 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,450 | $1,713,718 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
16,500 | $944,130 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
70,053 | $397,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
This page
|
2,102 | $393,662 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
3,000 | $367,740 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,115 | $268,681 |
All Filings in RVMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,662 | 2,102 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||